AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

ArriVent BioPharma Inc. C... (AVBP)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

28.50

0.26 (0.92%)

At close: Jan 28, 2025, 2:05 PM

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.

Boring Mode

Year	FY23	FY22	FY21
Revenue	n/a	n/a	n/a
Cost of Revenue	n/a	n/a	n/a
Gross Profit	n/a	n/a	n/a
Operating Income	-74.59M	-36.91M	-8.70M
Interest Income	5.26M	n/a	n/a
Pretax Income	-69.33M	-36.91M	-51.61M
Net Income	-69.33M	-36.91M	-51.61M
Selling & General & Admin	9.71M	6.47M	2.26M
Research & Development	64.88M	30.43M	6.43M
Other Expenses	n/a	n/a	n/a
Operating Expenses	74.59M	36.91M	8.70M
Interest Expense	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	-754.00K
Cost & Expenses	74.59M	36.91M	8.70M
Income Tax	n/a	-36.91M	-11.59M
Shares Outstanding (Basic)	31.96M	33.49M	33.49M
Shares Outstanding (Diluted)	31.96M	33.49M	33.49M
EPS (Basic)	-2.17	-1.1	-1.54
EPS (Diluted)	-2.17	-1.1	-1.54
EBITDA	-74.59M	-36.91M	-51.61M
Depreciation & Amortization	n/a	36.91M	11.59M